BPC-157 Read the full profile Site of action (Localized) Origin (Gastric juice fragment) Supports angiogenesis Typical research dose (200500 mcg/day) Typical frequency (12x daily) Typical cycle length (46 weeks) Subcutaneous injection WADA-banned since 2022 Studied alone (no pairing required) TB-500 Read the full profile Site of action (Systemic) Origin (Thymosin Beta-4 fragment) Supports angiogenesis Regulates actin / cell migration Typical research dose (25 mg/week) Typical frequency (23x weekly) Typical cycle length (48 weeks) Subcutaneous injection WADA-banned since 2022 Studied alone (no pairing required) Our top-rated vendor Our rankings are based solely on third-party lab testing rigor, COA transparency, and pricing no paid placements, no affiliate influence
These types of compounds work best when the basics are already in place
Rexar Technical Compound Datasheet (PDF) Molecular structure data and selected physicochemical properties can be consulted via: Dihexa on PubChem Dihexa is a synthetic oligopeptide-derived compound incorporating amino acid residues and an aliphatic acyl chain within a multi-amide framework
Products are supplied strictly as reference materials for in-vitro laboratory research by qualified professionals
BPC-157 shows stronger effect sizes in animal tendon models but that advantage cannot be extrapolated to humans without trials
Glutathione injections pair well with treatments such as vitamin C , B12 , NAD+ therapy , and IV hydration drips